The pathological upgrading after radical prostatectomy in low‐risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?
出版年份 2019 全文链接
标题
The pathological upgrading after radical prostatectomy in low‐risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?
作者
关键词
-
出版物
PROSTATE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-07-04
DOI
10.1002/pros.23873
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer
- (2018) Michelle Lancee et al. BJU INTERNATIONAL
- The new Epstein gleason score classification significantly reduces upgrading in prostate cancer patients
- (2018) Cosimo De Nunzio et al. EJSO
- Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology—Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help?
- (2018) Brian P. Calio et al. JOURNAL OF UROLOGY
- Metabolic syndrome increases the risk of upgrading and upstaging in patients with prostate cancer on biopsy: a radical prostatectomy multicenter cohort study
- (2018) De Nunzio Cosimo et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Prostate-specific Antigen Density Is a Good Predictor of Upstaging and Upgrading, According to the New Grading System: The Keys We Are Seeking May Be Already in Our Pocket
- (2018) Aldo Brassetti et al. UROLOGY
- Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance
- (2018) Deborah R. Kaye et al. BJU INTERNATIONAL
- Where Do Transrectal Ultrasound- and Magnetic Resonance Imaging-guided Biopsies Miss Significant Prostate Cancer?
- (2017) Lars Boesen et al. UROLOGY
- Role of neutrophil-to-lymphocyte ratio in prediction of Gleason score upgrading and disease upstaging in low-risk prostate cancer patients eligible for active surveillance
- (2016) Mehmet Ilker Gokce et al. CUAJ-Canadian Urological Association Journal
- A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment
- (2016) Leonard P. Bokhorst et al. EUROPEAN UROLOGY
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
- (2016) Freddie C. Hamdy et al. NEW ENGLAND JOURNAL OF MEDICINE
- A biopsy-integrated algorithm for determining Gleason 6 upgrading risk stratifies risk of active surveillance failure in prostate cancer
- (2016) M. L. Blute et al. WORLD JOURNAL OF UROLOGY
- What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series
- (2015) Giorgio Gandaglia et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6
- (2014) Hasmet Sarici et al. CUAJ-Canadian Urological Association Journal
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla
- (2012) Jeffrey W. Nix et al. BJU INTERNATIONAL
- Smaller prostate gland size and older age predict Gleason score upgrading
- (2011) Boris Gershman et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate Cancer
- (2009) Umberto Capitanio et al. UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started